Subproject for Institution # SP0053781

Project: Research project

Project Details

Description

Our ultimate goals are to understand, predict, prevent, and treat anthracycline-induced cardiotoxicity (AIC) in cancer patients receiving Anthracyclines (AC). Within the 5-year plan of this Transatlantic Network of Excellence, we intend to (see Figure):
Specific Aim 1. Elucidate the matrix of molecular signals that define the pathophysiology of AIC using in vitro and in vivo mouse models of AIC, hiPSC-CM, human myocardial slices.
Specific Aim 2. Identify and validate novel genetic/molecular signaling signatures to develop innovative biomarker strategies to identify patients at high-risk of experiencing AIC, using single cell transcriptome (SC-RNA-Seq) of human biopsy samples, blood samples and hiPSC-CM.
Specific Aim 3. Define druggable pathways and provide proof of concept pharmacological strategies for the prevention and treatment of AIC.
StatusActive
Effective start/end date1/1/2012/31/24

Funding

  • Leducq Foundation (19CVD02)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.